These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 34170813
1. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells. Zheng M, Mei Z, Junaid M, Tania M, Fu J, Chen HC, Khan MA. Anticancer Agents Med Chem; 2022; 22(6):1111-1118. PubMed ID: 34170813 [Abstract] [Full Text] [Related]
2. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells. Adinew GM, Messeha SS, Taka E, Badisa RB, Antonie LM, Soliman KFA. Nutrients; 2022 May 19; 14(10):. PubMed ID: 35631261 [Abstract] [Full Text] [Related]
3. Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53. Sutton KM, Greenshields AL, Hoskin DW. Nutr Cancer; 2014 May 19; 66(3):408-18. PubMed ID: 24579801 [Abstract] [Full Text] [Related]
4. Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro. Khan MA, Zheng M, Fu J, Tania M, Li J, Fu J. BMC Cancer; 2022 Jun 27; 22(1):707. PubMed ID: 35761256 [Abstract] [Full Text] [Related]
5. Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D3 triple therapy against colon cancer cells by attenuating the PI3K/AKT/mTOR pathway. Idris S, Refaat B, Almaimani RA, Ahmed HG, Ahmad J, Alhadrami M, El-Readi MZ, Elzubier ME, Alaufi HAA, Al-Amin B, Alghamdi AA, Bahwerth F, Minshawi F, Kabrah SM, Aslam A. Life Sci; 2022 May 01; 296():120442. PubMed ID: 35245520 [Abstract] [Full Text] [Related]
6. Thymoquinone Increases the Sensitivity of SW-480 Colon Cancer Cells to 5-Fluorouracil. Zeinali N, Mahmoudzadeh V, Anarjani A, Ebrahimnejad M, Yousefi B, Valizadeh A. Biomed Res Int; 2024 May 01; 2024():6231095. PubMed ID: 39015603 [Abstract] [Full Text] [Related]
7. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3. Ünal TD, Hamurcu Z, Delibaşı N, Çınar V, Güler A, Gökçe S, Nurdinov N, Ozpolat B. Anticancer Agents Med Chem; 2021 May 01; 21(3):355-364. PubMed ID: 32767958 [Abstract] [Full Text] [Related]
8. In Vitro Assessment of the Cytotoxic Effect of 5-Fluorouracil, Thymoquinone and their Combination on Tongue Squamous Cell Carcinoma Cell Line. Eloraby DAI, El-Gayar SF, El-Bolok AH, Ammar SG, ElShafei MM. Asian Pac J Cancer Prev; 2024 Jun 01; 25(6):2169-2176. PubMed ID: 38918680 [Abstract] [Full Text] [Related]
9. Modulation of gene expression by thymoquinone conjugated zinc oxide nanoparticles arrested cell cycle, DNA damage and increased apoptosis in triple negative breast cancer cell line MDA-MB-231. Sjs B, K K, A P, P H, B SR, S S. Drug Dev Ind Pharm; 2021 Dec 01; 47(12):1943-1951. PubMed ID: 35510706 [Abstract] [Full Text] [Related]
10. Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells. Adinew G, Messeha SS, Badisa R, Taka E, Soliman KFA. FASEB J; 2022 May 01; 36 Suppl 1():. PubMed ID: 35723877 [Abstract] [Full Text] [Related]
11. Effects of 5-fluorouracil, thymoquinone, and mammary stem cells' exosomes on in vitro cultured breast cancer cells. Abdelfattah-Hassan A, Ibrahim D, Saleh AA, Kishawy ATY, Mohamed RHA, Khater SI. Open Vet J; 2024 Jan 01; 14(1):525-533. PubMed ID: 38633189 [Abstract] [Full Text] [Related]
12. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Kabil N, Bayraktar R, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, Ozpolat B. Breast Cancer Res Treat; 2018 Oct 01; 171(3):593-605. PubMed ID: 29971628 [Abstract] [Full Text] [Related]
13. Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo. Lei X, Lv X, Liu M, Yang Z, Ji M, Guo X, Dong W. Biochem Biophys Res Commun; 2012 Jan 13; 417(2):864-8. PubMed ID: 22206670 [Abstract] [Full Text] [Related]
14. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer. Şakalar Ç, İzgi K, İskender B, Sezen S, Aksu H, Çakır M, Kurt B, Turan A, Canatan H. Tumour Biol; 2016 Apr 13; 37(4):4467-77. PubMed ID: 26500095 [Abstract] [Full Text] [Related]
15. Effect of thymoquinone on pharmacokinetics of 5-fluorouracil in rats and its effect on human cell line in vitro. Eftekhar SP, Kazemi S, Moghadamnia AA. Hum Exp Toxicol; 2022 Apr 13; 41():9603271221145422. PubMed ID: 36510676 [Abstract] [Full Text] [Related]
16. TQFL12, a novel synthetic derivative of TQ, inhibits triple-negative breast cancer metastasis and invasion through activating AMPK/ACC pathway. Wei C, Zou H, Xiao T, Liu X, Wang Q, Cheng J, Fu S, Peng J, Xie X, Fu J. J Cell Mol Med; 2021 Nov 13; 25(21):10101-10110. PubMed ID: 34609056 [Abstract] [Full Text] [Related]
17. Hijacking 5-Fluorouracil Chemoresistance in Triple Negative Breast Cancer via microRNAs-Loaded Chitosan Nanoparticles. Fahmy SA, Mahdy NK, Mohamed AH, Mokhtar FA, Youness RA. Int J Mol Sci; 2024 Feb 08; 25(4):. PubMed ID: 38396746 [Abstract] [Full Text] [Related]
18. Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer. Barkat MA, Harshita, Ahmad J, Khan MA, Beg S, Ahmad FJ. Curr Drug Targets; 2018 Feb 08; 19(1):70-80. PubMed ID: 28606050 [Abstract] [Full Text] [Related]
19. Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats. Kensara OA, El-Shemi AG, Mohamed AM, Refaat B, Idris S, Ahmad J. Drug Des Devel Ther; 2016 Feb 08; 10():2239-53. PubMed ID: 27468227 [Abstract] [Full Text] [Related]
20. Establishment of a 5-fluorouracil-resistant triple-negative breast cancer cell line. Takahashi K, Tanaka M, Inagaki A, Wanibuchi H, Izumi Y, Miura K, Nagayama K, Shiota M, Iwao H. Int J Oncol; 2013 Dec 08; 43(6):1985-91. PubMed ID: 24126575 [Abstract] [Full Text] [Related] Page: [Next] [New Search]